CD19 and Parkinson disease: The frequencies of cells expressing CD45+ (total leukocytes), CD3+CD14−CD19− (T cells), CD3−CD14+CD19+ (B cells/monocytes), and CD3−CD14−CD19− (NK cells) were found to be comparable between PD and control groups (Fig. 1B).